Evidence map›Paper›PMID 34250390›Full record

ArticleJCO precision oncology2021

Lung Cancer in Li-Fraumeni Syndrome.

Kathleen Kerrigan, Jessica Chan, Jennie Vagher, Wendy Kohlmann, Anne Naumer, Jo Anson, Sara Low, Joshua Schiffman, Luke Maese

Abstract readCase Reports
In one paragraph

Article in JCO precision oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Current status of molecular diagnostics for lung cancer.Exploration of targeted anti-tumor therapy · 2024
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kathleen KerriganDepartment of Internal Medicine, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.ORCID 0000-0001-9144-8342
Jessica ChanDepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT.ORCID 0000-0001-9104-118X
Jennie VagherDepartment of Genetic Counseling, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.
Wendy KohlmannDepartment of Genetic Counseling, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.ORCID 0000-0002-9134-9640
Anne NaumerDepartment of Genetic Counseling, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.
Jo AnsonDepartment of Genetic Counseling, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.
Sara LowDepartment of Genetic Counseling, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.
Joshua SchiffmanDepartment of Pediatrics, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.ORCID 0000-0002-6968-7694
Luke MaeseDepartment of Pediatrics, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.ORCID 0000-0002-8739-9100

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
NCI NIH HHS P30 CA042014
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultFemaleHumansLi-Fraumeni SyndromeLung NeoplasmsMaleMiddle Aged

Identifiers

PMID34250390
PMCPMC8232233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.